AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Food Science and Human Wellness Article
PDF (501.6 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

What could probiotic do for us?

Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore 117597, Singapore

Peer review under responsibility of Beijing Academy of Food Sciences.

Show Author Information

Abstract

Gastrointestinal microbes play important roles in the health and disease of the host. There are many documented evidences which demonstrated that disturbance of intestinal microbiota is linked to the risk of developing infectious, inflammatory and allergic diseases. Human intestine is home for a complex consortium of 1013–1014 microbial cells. Interactions between the intestinal microbes, pathogens and the host lead to exclusion of toxins (mycotoxins) and pathogens (colonization resistance), interference in disease progression as demonstrated in the prevention of oral infection, dental caries, diarrhoeas (Antibiotic Associated Diarrhoea, Travellers’ Diarrhoea and Rotavirus Diarrhoea), postoperative infection, respiratory infection and certain cancers. The group of beneficial intestinal microbes termed probiotics alter intestinal epithelial cell tight junction and immunological functions. Lately, laboratory and clinical studies demonstrated gut-brain axis communication and intestinal microbial (both pathogens and probiotics) modulation of host psycho-neuroimmunological functions, in relation to depression, anxiety and memory dysfunction. These open up many possibilities of probiotics supplementation for moderating intestinal microbiota as an approach in disease prevention and treatment.

References

[1]

J. Rhodes, The role of Escherichia coli in inflammatory bowel disease, Gut 56 (2007) 610-612.
Crossref Google Scholar
[2]

B. Willing, J. Halfvarson, J. Dicksved, et al., Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease, Inflamm. Bowel Dis. 15 (2009) 653-660.
Crossref Google Scholar
[3]

G.C. Zella, E.J. Hait, T. Glavan, et al., Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis, Inflamm. Bowel Dis. 17 (2011) 1092-1100.
Crossref Google Scholar
[4]
FAO/WHO, Joint Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, October 2001.
[5]

T.D. Lawley, A.W. Walker, Intestinal colonization resistance, Immunology 138 (1) (2013) 1-11.
Crossref Google Scholar
[6]

S. Salminen, G.R. Gibson, A.L. McCartney, E. Isolauri, Influence of mode of delivery on gut microbiota composition in seven year old children, Gut 53 (2004) 1388-1389.
Crossref Google Scholar
[7]

M.G. Dominguez-Belloa, E.K. Costellob, M. Contrerasc, et al., Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns, Proc. Natl. Acad. Sci. U.S.A. 107 (26) (2010) 11971-11975.
Crossref Google Scholar
[8]

O. Kolokotroni, N. Middleton, M. Gavatha, et al., Asthma and atopy in children born by caesarean section: effect modification by family history of allergies – a population based cross-sectional study, BMC Pediatr. 12 (2012) 179-188.
Crossref Google Scholar
[9]

P. Bager, J. Wohlfahrt, T. Westergaard, Caesarean delivery and risk of atopy and allergic disease: meta-analyses, Clin. Exp. Allergy 38 (4) (2008) 634-642.
Crossref Google Scholar
[10]

Y.K. Lee, K.Y. Puong, Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate, Br. J. Nutr. 88 (Suppl. 1) (2002) S101-S108.
Crossref Google Scholar
[11]

C. de Filippo, D. Cavalieria, M.D. Paolab, et al., Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa, Proc. Natl. Acad. Sci. U.S.A. 107 (2010) 14691-14696.
Crossref Google Scholar
[12]

J.C. Zhang, Z. Guo, A.A.Q. Lim, et al., Mongolians core gut microbiota and its correlation with seasonal dietary changes, Sci. Rep. 4 (2014) 5001, http://dx.doi.org/10.1038/srep05001.
Crossref Google Scholar
[13]

V. Gotz, J.A. Romankiewicz, J. Moss, H.W. Murray, Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation, Am. J. Hosp. Pharm. 36 (1979) 754-757.
Crossref Google Scholar
[14]

Y.K. Lee, C.Y. Lim, W.L. Teng, et al., Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria, Appl. Environ. Microbiol. 66 (2000) 3692-3697.
Crossref Google Scholar
[15]

C.B. Maassen, C. van Holten-Neelen, F. Balk, et al., Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains, Vaccine 18 (23) (2000) 2613-2623.
Crossref Google Scholar
[16]

M. Kalliomäki, S. Salminen, H. Arvilommi, et al., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial, Lancet 357 (9262) (2001) 1076-1079.
Crossref Google Scholar
[17]

M. Kalliomäki, S. Salminen, T. Poussa, et al., Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial, Lancet 361 (9372) (2003) 1869-1871.
Crossref Google Scholar
[18]

M. Kalliomäki, S. Salminen, T. Poussa, E. Isolauri, Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial, J. Allergy Clin. Immunol. 119 (4) (2007) 1019-1021.
Crossref Google Scholar
[19]

P. Gionchetti, F. Rizzello, A. Venturi, et al., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology 119 (2) (2000) 305-309.
Crossref Google Scholar
[20]

R. Bibiloni, R.N. Fedorak, G.W. Tannock, et al., VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis, Am. J. Gastroenterol. 100 (7) (2005) 1539-1546.
Crossref Google Scholar
[21]

C. Koebnick, I. Wagner, P. Leitzmann, et al., Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation, Can. J. Gastroenterol. 17 (11) (2003) 655-659.
Crossref Google Scholar
[22]

S. Nobaek, M.L. Johansson, G. Molin, et al., Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am. J. Gastroenterol. 95 (5) (2000) 1231-1238.
Crossref Google Scholar
[23]

M.A. O'Sullivan, C.A. O’Morain, Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study, Dig. Liver Dis. 32 (4) (2000) 294-301.
Crossref Google Scholar
[24]

M. de Vrese, P. Winkler, P. Rautenberg, et al., Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial, Vaccine 24 (44–46) (2006) 6670-6674.
Crossref Google Scholar
[25]

M. de Vrese, P. Winkler, P. Rautenberg, et al., Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial, Clin. Nutr. 24 (4) (2005) 481-491.
Crossref Google Scholar
[26]

A. Homayouni, P. Bastani, S. Ziyadi, et al., Effects of probiotics on the recurrence of bacterial vaginosis: a review, J. Low. Genit. Tract Dis. 18 (1) (2014) 79-86.
Crossref Google Scholar
[27]

P.M. Grin, P.M. Kowalewska, W. Alhazzan, A.E. Fox-Robichaud, Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis, Can. J. Urol. 20 (1) (2013) 6607-6614.
Google Scholar
[28]

B. Vitali, F. Cruciani, M.E. Baldassarre, et al., Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion, BMC Microbiol. 12 (2012) 236-250.
Crossref Google Scholar
[29]

M. Eichholzer, F. Gutzwiller, Dietary nitrates, nitrites, and N-nitroso compounds and cancer risk: a review of the epidemiologic evidence, Nutr. Rev. 56 (4) (1998) 95-105.
Crossref Google Scholar
[30]

E. Giovannucci, E.B. Rimm, M.J. Stampfer, et al., Intake of fat, meat, and fiber in relation to risk of colon cancer in men, Cancer Res. 54 (1994) 2390-2397.
Google Scholar
[31]

K.T. Chung, The etiology of bladder cancer and its prevention, J. Cancer Sci. Ther. 5 (10) (2013) 346-361.
Crossref Google Scholar
[32]

M. Blaut, T. Clavel, Metabolic diversity of the intestinal microbiota: implications for health and disease, J. Nutr. 137 (3) (2007) 751S-755S.
Crossref Google Scholar
[33]

R.W. Chadwick, S.E. George, L.D. Claxton, Role of gastrointestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens, Drug Metab. Rev. 24 (1992) 425-492.
Crossref Google Scholar
[34]

A.M. Robertson, Roles of endogenous substances and bacteria in colorectal cancer, Mutat. Res. 290 (1993) 71-78.
Crossref Google Scholar
[35]

M. Nanno, I. Kato, T. Kobayashi, K. Shida, Biological effects of probiotics: what impact does Lactobacillus casei Shirota have on us? Int. J. Immunopathol. Pharmacol. 24 (1 Suppl.) (2011) 45S-50S.
Google Scholar
[36]

S. Naito, H. Koga, A. Yamaguchi, et al., Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer, J. Urol. 179 (2008) 485-490.
Crossref Google Scholar
[37]

Y. Ohashi, S. Nakai, T. Tsukamoto, et al., Habitual intake of lactic acid bacteria and risk reduction of bladder cancer, Urol. Int. 68 (2002) 273-280.
Crossref Google Scholar
[38]

P.D. Cani, J. Amar, M.A. Iglesias, et al., Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes 56 (7) (2007) 1761-1772.
Crossref Google Scholar
[39]

A. Everard, P.D. Cani, Diabetes, obesity and gut microbiota, Best Pract. Res. Clin. Gastroenterol. 27 (1) (2013) 73-83.
Crossref Google Scholar
[40]

A. Everard, C. Belzer, L. Geurts, et al., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc. Natl. Acad. Sci. U.S.A. 110 (22) (2013) 9066-9071.
Crossref Google Scholar
[41]

P.D. Cani, R. Bibiloni, C. Knauf, et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes 57 (6) (2008) 1470-1481.
Crossref Google Scholar
[42]

L. Desbonnet, L. Garrett, G. Clarke, et al., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression, Neuroscience 170 (2010) 1179-1188.
Crossref Google Scholar
[43]

P.K. Singh, K. Chopra, A. Kuhad, I.P. Kaur, Role of Lactobacillus acidophilus loaded floating beads in chronic fatigue syndrome: behavioural and biochemical evidences, Neurogastroenterol. Motil. 24 (4) (2012) 366-376.
Crossref Google Scholar
[44]

D. Benton, C. Williams, A. Brown, Impact of consuming a milk drink containing a probiotic on mood and cognition, Eur. J. Clin. Nutr. 61 (2007) 355-361.
Crossref Google Scholar
[45]

A.V. Rao, A.C. Bested, T.M. Beaulne, et al., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome, Gut Pathog. 1 (2009) 6-12.
Crossref Google Scholar
[46]

M.G. Gareau, E. Wine, D.M. Rodrigues, et al., Bacterial infection causes stress-induced memory dysfunction in mice, Gut 60 (2011) 307-317.
Crossref Google Scholar
[47]

M.S. Collins, M. Surette, P. Bercik, The interplay between the intestinal microbiota and the brain, Nat. Rev. Microbiol. 10 (2012) 735-742.
Crossref Google Scholar
[48]

J.G. Sanger, K. Lee, Hormones of the gut–brain axis as targets for the treatment of upper gastrointestinal disorders, Nat. Rev. Drug Discov. 7 (2008) 241-254.
Crossref Google Scholar
Food Science and Human Wellness
Volume 3 Issue 2,
June 2014
Pages 47-50
DOI: 10.1016/j.fshw.2014.06.001
Cite this article:
Lee YK. What could probiotic do for us?. Food Science and Human Wellness, 2014, 3(2): 47-50. https://doi.org/10.1016/j.fshw.2014.06.001

449

Views

11

Downloads

8

Crossref

N/A

Web of Science

12

Scopus

0

CSCD

Altmetrics
Received: 28 May 2014
Accepted: 06 June 2014
Published: 17 June 2014
© 2014 Beijing Academy of Food Sciences.
Return